INTRODUCTION
Respiratory tract infection (RTI) is one of the most common reasons why children present to primary care. A recent review by the UK's National Institute for Health and Care Excellence (NICE) concluded that antibiotics do not confer a clinically significant reduction in the time needed to recover from an RTI, and recommended that antibiotics are not prescribed for RTI in children who are otherwise healthy. 1 However, despite this, prescribing rates remain high 2 and are increasing 3 in UK general practice. This results in the treatment of children who experience no clinical benefit, yet are exposed to the potential adverse effect of antibiotics. This practice increases the potential for development of antimicrobial resistance. 4 No diagnostic or prognostic rule has been developed to distinguish bacterial from viral RTI that would be expected to respond to antibiotics. In the absence of this information, a diagnostic gap exists between the presentation of RTI and the appropriate management. This leads to diagnostic uncertainty, which is reflected in a wide variation in antibiotic prescribing rates between clinicians, 5 practices, 6 and countries. 7 The aim of this review was to identify the extent of evidence-reporting associations between clinical presentation and the detection of microbes in the upper respiratory tract (URT) in children presenting to healthcare services with RTIs associated with acute cough -cough being the most common presenting symptom of RTI 8 -and to conduct meta-analysis where appropriate.
METHOD

Search strategy
The search strategy was designed to identify observational studies and reviews that reported the relationships between clinical presentation and microbes sampled from the URT in children presenting with cough. Included studies were required to present data at the level of individual patients, and could be conducted in any country and published in any language. MEDLINE, Embase, and the Cochrane database using the OVID platform were searched on 30 November 2012, and the search was updated on 12 April 2014.
The MEDLINE search strategy is presented in Appendix 1 and used combinations of MeSH terms and text words for clinical symptoms and signs, disease causation, microbes, and clinical diagnoses. The search strategy was adapted for use in both MEDLINE and Embase. The search was not limited to the English language,
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Method
A literature search identified articles reporting relationships between individual symptoms and/or signs, and microbes detected from URT samples. Associations between pathogens and symptoms or signs were summarised, and meta-analysis conducted where possible.
Results
There were 9984 articles identified, of which 28 met inclusion criteria. Studies identified 30 symptoms and 41 signs for 23 microbes, yielding 1704 potential associations, of which only 226 (13%) have presently been investigated. Of these, relevant statistical analyses were presented for 175 associations, of which 25% were significant. Meta-analysis demonstrated significant relationships between respiratory syncytial virus (RSV) detection and chest retractions (pooled odds ratio [OR] 1.9, 95% confidence interval [CI] = 1.6 to 2.3), wheeze (pooled OR 1.7, 95% CI = 1.5 to 2.0), and crepitations/crackles (pooled OR 1.7, 95% CI = 1.3 to 2.2).
Conclusions
There was an absence of evidence for URT pathogens other than RSV. The meta-analysis identified clinical signs associated with RSV detection, suggesting clinical presentation may offer some, albeit poor, diagnostic value. Further research is urgently needed to establish the value of symptoms and signs in determining microbiological aetiology and improve targeting of antibiotics in primary care.
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Clinical presentation and microbiological diagnosis in paediatric respiratory tract infection:
a systematic review no time restrictions were applied, and translations were obtained where required. Reference lists of all full-text articles were also screened.
Study selection
Studies eligible for inclusion were all peerreviewed, quantitative studies reporting microbiological and clinical data from children presenting to a healthcare service or research team with a diagnosis or symptoms of an RTI associated with cough. Studies recruiting from primary care, secondary care, and community settings were included. Studies were excluded if data presented were selected based on a subgroup of children with positive microbiology results, or if children were recruited from intensive care or from a population with a high prevalence of pre-existing chronic disease or immune incompetence. Full inclusion and exclusion criteria are listed in Box 1.
Titles and abstracts of all articles identified were reviewed by one author, and those that were not relevant were excluded. Twenty per cent of abstracts were independently reviewed by one of two other authors, with good agreement (κ 0.89). Full-text copies of all included articles were independently reviewed by three authors, and any eligibility disagreements resolved by discussion.
Data extraction and quality assessment Data were extracted from studies included in the review using a purpose-designed Access form and Excel spreadsheet. Descriptive variables extracted were participant age, study setting, design, country of recruitment, URT sample site, laboratory methods, microbes identified, analysis methods, whether children with prior antibiotic use were included in the study, and whether study inclusion criteria specified any named RTIs. Outcome data extracted were any symptoms and signs reported that were related to the clinical presentation of RTI. Quality assessment was conducted for all included articles using a purpose-designed form containing criteria based on recommendations from the GRADE guidelines and QUADAS-2 checklist.
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Data synthesis and analysis Visual representation of the number of relationships sought was achieved by crosstabulation of reported symptoms and signs against the respiratory pathogens identified. Where three or more studies reported raw data for an association between a pathogen and a symptom or sign, data were extracted, results checked for homogeneity, and metaanalysis carried out.
Statistical analysis was completed in STATA (version 12). Pooled odds ratios (OR) were obtained by fixed-effects metaanalysis to investigate the odds of pathogen detection in the presence of individual symptoms and signs. Heterogeneity was assessed using the I 2 statistic, and the possibility of publication bias was assessed using funnel plots. a. The strength of associations between specific symptoms and/or signs and pathogens identified from respiratory tract samples; or b. Raw data cross-tabulating the incidence of specific symptoms and/or signs against pathogens identified from respiratory tract samples. 4. Studies report data from children; studies that recruit both adult and child participants must report child data separately from adult data.
RESULTS
Study characteristics
Exclusion criteria 1. Studies where children are selected for entry into the study on the basis of positive microbiology results. 2. Studies where data is not presented from the whole cohort, but from a subgroup selected on the basis of microbiology results. 3. Microbiology results from pulmonary, blood, urine, or faecal samples. 4. Study participants recruited from intensive care. 5. Study participants recruited from a population of children with a high prevalence of pre-existing chronic disease or immune incompetence.
were read. Twenty-eight articles were eligible for inclusion in the review ( Figure 1 ). Raw data were presented by three or more studies for the associations between six individual clinical signs and pathogen detection, and this data, extracted from 10 studies, were included in the meta-analysis.
Study characteristics are summarised in Table 1 . Half of studies (14 out of 28, 50% of total) recruited only infants aged 0-1 years, 1 out of 28 (4%) recruited only children aged from 2-17 years, and 3 out of 28 (11%) recruited infants and children aged from 0-17 years. All studies used samples taken from the nasopharynx, with the majority (18 out of 28, 64%) using nasopharyngeal aspirates. Laboratory methods of pathogen identification varied within and between studies, and included polymerase chain reaction (PCR) (used in 18 out of 28 studies, 65%), bacterial culture (4 out of 28 studies, 14%), assays (real-time analyte specific reagent or enzyme-linked immunoassay) (4 out of 28, 14%), and direct immunofluorescence (5 out of 28, 18%). The majority of studies (20 out of 28, 71%) were set in high-income countries.
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Quality assessments are summarised in Appendix 2. Studies were found to be of generally good quality and no study was excluded from this review on the basis of poor quality.
Symptoms, signs, and microbes investigated in the literature
Data were sought for 24 individual pathogens and were identified for 71 symptoms and signs, yielding 1704 potential comparisons (Appendix 3). Of the potential comparisons 226 (13%) were investigated by one or more study, within which 19% showed statistically significant associations; 58% showed no significant association; and 23% presented no relevant statistical analysis ( Figure 2 ).
Signs associated with RSV detection
Six associations were identified that were examined by three or more studies presenting raw data. All six associations described the relationships between respiratory syncytial virus (RSV) and clinical signs. Raw data were extracted, and metaanalysis found significant associations between RSV detection and chest retractions (OR 1.9, 95% CI = 1.6 to 2.2, I ² = 48%, P-value for I ² statistic 0.074), wheeze (OR 1.7, 95% CI = 1.5 to 2.0, I ² = 37%, P = 0.134), and crepitations/crackles (OR 1.7, 95% CI = 1.4 to 2.2, I ² = 0%, P = 0.842) (Figure 3 ). Rales were not significantly associated with RSV (OR 1.2, 95% CI = 0.98 to 1.4, I ² = 0%, P<0.669), and nor was fever (OR 0.97, 95% CI = 0.7 to 1.3, I ² = 0%, P = 0.507). Results of meta-analysis could not be considered for increased respiratory rate, as the data showed considerable heterogeneity (OR 5.3, 95% CI = 3.9 to 7.0, I ² = 93%, P<0.001).
Publication bias
Publication bias was assessed in the data for wheeze and chest retractions using funnel plots (Appendices 4 and 5). Some evidence of positive publication bias was seen for chest retractions, but there was no evidence of publication bias for wheeze. There were insufficient data to assess publication bias for rales, crepitations/crackles, fever, or increased respiratory rate.
DISCUSSION Summary
There is an absence of evidence evaluating the link between many clinical symptoms or signs and URT respiratory pathogens in children presenting to healthcare services with RTI-associated acute cough. Metaanalysis shows that some clinical signs (chest retractions, wheeze, and crepitations/ crackles) are associated with URT detection of RSV. These results are applicable to children presenting to primary or secondary care with cough. However, caution should be taken in applying them beyond this population due to the effect of age on both URT flora and symptomatic presentation. guidelines. 12 Included are studies reporting either raw data or statistical results for associations between clinical presentation and URT respiratory pathogen detection, and have presented a unique overview of current knowledge. URT samples were selected for this review as this is the most accessible and acceptable site for primary care microbiological sampling. It is here that future point-of-care tests would most easily sample respiratory tract pathogens.
Strengths and limitations
Reference lists of included articles were hand-searched, but it was beyond the scope of this investigation to search grey literature or conference proceedings.
Absence of multivariable analysis in the published literature means that, while no clear pattern is demonstrable between individual symptoms and signs, important independent associations may have been confounded by the presence of other symptoms and signs. Similarly, studies that failed to test for, or analyse, a broad range of respiratory pathogens may be affected by confounding due to the presence of an untested, or unadjusted for, microbe. Furthermore, the possibility of asymptomatic 'carrier states' was not investigated by these studies.
A lack of consensus was identified regarding the definition of continuous objective signs such as 'hypoxia' and 'fever'. For example, some studies defined 'hypoxaemia' as a blood oxygen saturation level of <92%, [13] [14] [15] while in others the cutoff limits were <95%. 16 In the interest of brevity, results for multiple definitions of these signs were combined into a single row in the tables. The use of international guidelines to define such terms in research, or the reporting of raw data, would increase the potential for meaningful comparisons between studies, and quantitative synthesis.
A wide variety of laboratory methods are employed to detect microbes in URT samples, and in many publications little or no validation data or standardisation of methods were described. Further to this, the use of URT samples as the diagnostic reference standard in this review may represent a poor measure of aetiology.
Comparison with existing literature
Previous work has demonstrated that clinicians use symptoms and signs to inform prescribing decisions in patients with RTI. 17 Evidence from existing meta-analyses suggests that Mycoplasma pneumoniae and influenza A and B may be associated with symptoms and signs; however, settings were not limited to primary care and reference standards included serological diagnosis. 18, 19 Additionally, a recent study demonstrated that clinical features are moderately diagnostic for the detection of streptococci from the throat in patients presenting to primary care with tonsillitis.
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Implications for research and practice Clinical guidelines in the UK and Europe advise that prescribing decisions are made based on the severity of disease or potential for complications. 1, 21, 22 Despite these recommendations, however, previous research has demonstrated that European clinicians use clinical presentation to help them assess the likelihood of bacterial aetiology in their decision making. 17, 23 Overall, given the absence of evidence in this area, clinicians should be cautious about using clinical features to distinguish the 'bacterial' or 'viral' status of RTI in children in primary care. In the absence of a gold-standard aetiological test, further research is needed to establish whether URT microbes are associated with clinical presentation and, more importantly, with prognosis. High-quality, large-scale observational studies investigating a broad panel of respiratory pathogens are lacking, particularly in the primary care setting.
Future research should include other causality metrics in study design, for example, investigating the relationship between microbe quantification and clinical presentation, which could be used to help distinguish microbial aetiology from incidental carriage or asymptomatic infection. Other biomarkers, such as C-reactive protein and procalcitonin, have also been investigated as potential diagnostic aids in RTI 24 and their use could be considered in conjunction with URT samples.
This review demonstrates a significant gap in the evidence for using clinical presentation to make a microbiological diagnosis for children presenting with RTI. That said, the meta-analysis shows that clinical presentation is associated with the detection of RSV from the URT. This suggests that clinical presentation could be associated with the detection of other easily accessible URT microbes, which could be used to develop future diagnostic strategies and improve targeting of antimicrobials.
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